Press releases and news of the Cluster of Excellence

Researchers at the FZB have defined the areas in which the development of resistance to two important tuberculosis drugs is favored.

A specific intestinal bacterium produces sphingolipids, via an alternative metabolic pathway, that provide host protection against infection. 
 

The new Research Training Group GRK3095 will investigate the mechanisms by which antibodies trigger either protective or disease-causing responses in…

Immunologist from the Cluster of Excellence PMI receives prestigious European Research Council grant for work on regulatory T cells.

The Cluster of Excellence is once again making its way to Kiel Week this year with plenty of information and exciting content in its luggage.

Research team from the Cluster of Excellence PMI shows elevated immune responses toward Epstein-Barr virus in individuals with primary sclerosing…

Researchers from the Cluster of Excellence PMI reveal how metabolic activity — and thus communication between gut tissue and microbiome — collapses…

Research team with the participatipn of PMI members has computer-identified drug candidates successfully confirmed by laboratory experiments.

The Cluster of Excellence PMI will receive funding for another seven years, enabling it to continue its successful research into chronic inflammatory…

With light installations and a music video, the Cluster of Excellence PMI and Kiel University are drawing attention to chronic inflammatory bowel…